TechMark movers: Biocompatibles up on Astra deal

LONDON (ShareCast) – Shares in Biocompatibles rose after the stent specialist signed a diabetes drug agreement with AstraZeneca. It has signed product development and option-to-License agreements with AstraZeneca for a proprietary GLP-1 analogue invented

Leave a Reply